ATAGI advice on the use of Bexsero® vaccine
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
This document contains Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers about the use of Bexsero®, a recombinant multicomponent meningococcal B vaccine (4CMenB).
It includes information about transport, storage and handling, dosage and administration, recommendations, contraindications, adverse events and references to more detailed information.